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Introduction
Fixed drug eruption (FDE) is a well-recognised localized
cutaneous adverse drug reaction, characterized by its
recurrence in the same sites upon re-exposure to the
causative drug. We aimed to better understand the epi-
demiology, clinical features as well as the causative
drugs of fixed drug eruptions in Singapore.
Methods
A retrospective chart review of all cases with suspected
FDE seen in National Skin Centre, Singapore between
2008 and 2012 was performed. All cases were classified
into whether the diagnosis of FDE was definite, probable,
possible or unlikely based on WHO-UMC Causality
Assessment criteria. Patients were classified as probable
FDE if there was typical cutaneous eruption which was
temporally related to exposure to a clearly-identified
drug and not attributable to other causes. Definite cases
had confirmation with positive drug patch test or provo-
cation test.
Results
There were 126 patients who were seen for suspected
FDE. Patients were evaluated with history-taking and phy-
sical examination. Skin biopsy or drug patch or provoca-
tion tests were performed when indicated in consenting
patients. Almost half of the cases (46.0%) had definite or
probable diagnosis of FDE with identification of the causa-
tive drug. Seven percent of patients were considered unli-
kely to have FDE, while 46.8% of the patients had possible
diagnosis of FDE for which the causative drug could not
be determined or the patient declined further evaluation.
Of the 58 patients with definite or probable FDE, 70.7%
presented with more than 1 site of involvement and 20.7%
had genital lesions. Two patients had positive drug patch
tests while 7 patients had positive drug provocation tests.
Four patients had drug provocation tests to exclude other
possible causative drugs. The most common causative
drugs were non-steroidal anti-inflammatory drugs
(NSAIDs), paracetamol and doxycycline. FDE was caused
by anti-histamines in 4 cases, with 1 case having positive
patch test to both hydroxyzine and cetirizine.
Conclusion
It is a well-recognised fact that FDE may be caused by
NSAIDs, paracetamol and doxycycline. Clinicians should
also be aware that other commonly used drugs such as
antihistamines, which are often thought to be safe, may
occasionally cause FDE. Cross-reactivity between various
antihistamines in causing FDE may also seen. Drug
patch or provocation tests should be considered for
complete evaluation.
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